These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Genetic and Environmental Influences on Regional Brain Uptake of 18F-FDG: A PET Study on Monozygotic and Dizygotic Twins. Watanabe S, Kato H, Shimosegawa E, Hatazawa J. J Nucl Med; 2016 Mar; 57(3):392-7. PubMed ID: 26585060 [Abstract] [Full Text] [Related]
6. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [Abstract] [Full Text] [Related]
9. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A. Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944 [Abstract] [Full Text] [Related]
10. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization. Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P. Neurosci Lett; 2013 Feb 08; 534():12-7. PubMed ID: 23182881 [Abstract] [Full Text] [Related]
12. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease. Liguori C, Chiaravalloti A, Sancesario G, Stefani A, Sancesario GM, Mercuri NB, Schillaci O, Pierantozzi M. Eur J Nucl Med Mol Imaging; 2016 Oct 08; 43(11):2040-9. PubMed ID: 27221635 [Abstract] [Full Text] [Related]
18. A 90-year-old monozygotic female twin pair discordant for Alzheimer's disease. Järvenpää T, Räihä I, Kaprio J, Koskenvuo M, Laine M, Kurki T, Viljanen T, Rinne JO. Neurobiol Aging; 2003 Nov 08; 24(7):941-5. PubMed ID: 12928054 [Abstract] [Full Text] [Related]
19. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB. Am J Psychiatry; 1996 Oct 08; 153(10):1261-8. PubMed ID: 8831432 [Abstract] [Full Text] [Related]
20. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A. Eur J Nucl Med Mol Imaging; 2003 Aug 08; 30(8):1104-13. PubMed ID: 12764551 [Abstract] [Full Text] [Related] Page: [Next] [New Search]